BVF

BVF as of Sept. 30, 2017

Portfolio Holdings for BVF

BVF holds 37 positions in its portfolio as reported in the September 2017 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Array BioPharma 10.0 $79M 6.4M 12.30
Blueprint Medicines (BPMC) 8.9 $70M 1.0M 69.67
Chemocentryx 7.2 $56M 7.6M 7.42
Anaptysbio Inc Common (ANAB) 6.1 $48M 1.4M 34.95
Concert Pharmaceuticals I equity 5.9 $46M 3.1M 14.75
Glycomimetics (GLYC) 5.7 $45M 3.2M 13.99
Ironwood Pharmaceuticals (IRWD) 5.7 $45M 2.8M 15.77
Cytomx Therapeutics (CTMX) 5.2 $41M 2.2M 18.17
Xoma Corp Del (XOMA) 3.8 $30M 1.5M 19.65
Biolinerx Ltd-spons 3.7 $29M 26M 1.12
Cti Biopharma 3.5 $27M 8.6M 3.19
Loxo Oncology 2.8 $22M 238k 92.12
Kura Oncology (KURA) 2.6 $20M 1.4M 14.95
Oncomed Pharmaceuticals 2.5 $20M 4.4M 4.52
Zealand Pharma A/s- 2.4 $19M 1.0M 19.20
Cytokinetics (CYTK) 2.3 $18M 1.2M 14.50
Pieris Pharmaceuticals (PIRS) 2.2 $17M 3.0M 5.76
Regulus Therapeutics 2.1 $16M 13M 1.25
Intra Cellular Therapies (ITCI) 1.9 $15M 950k 15.78
Tocagen 1.7 $13M 1.1M 12.46
Cascadian Therapeutics 1.6 $13M 3.1M 4.09
Spring Bk Pharmaceuticals In 1.4 $11M 653k 16.84
Xenon Pharmaceuticals (XENE) 1.4 $11M 3.6M 2.95
Infinity Pharmaceuticals (INFIQ) 1.3 $11M 7.9M 1.33
Gtx Inc Del 1.2 $9.1M 1.1M 8.22
Forward Pharma A/s 1.1 $8.6M 1.5M 5.89
ArQule 1.0 $8.2M 7.4M 1.11
Alpine Immune Sciences (ALPN) 1.0 $7.8M 676k 11.60
Corvus Pharmaceuticals (CRVS) 0.9 $7.3M 459k 15.94
Molecular Templates 0.6 $5.0M 724k 6.97
Orexigen Therapeutics Inc. 144a 2 3/4% Due 12/1/2020 Jd1 note 2.750%12/0 0.6 $4.8M 10M 0.48
Sunesis Pharmaceuticals Inc Ne 0.5 $4.0M 2.0M 1.94
Contrafect 0.5 $3.9M 3.5M 1.11
Aduro Biotech 0.2 $2.0M 185k 10.65
Orexigen Therapeutics 0.2 $1.6M 735k 2.12
Anthera Pharmaceuticals (ANTH) 0.2 $1.4M 1.0M 1.44
Pain Therapeutics 0.2 $1.3M 326k 4.07